We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Skin Patch Monitors Tumor Size and Sends Data to Smartphone

By HospiMedica International staff writers
Posted on 26 Jan 2024

Certain tumors form just beneath the skin's surface, and doctors often opt not to remove them immediately for various medical reasons. More...

These tumors are generally managed with medications and radiation therapy. In these situations, it's crucial for healthcare professionals to regularly assess the tumor's size to evaluate the effectiveness of the treatments. This typically requires patients to visit a medical facility for tests like MRIs to measure the tumor. Now, researchers have created a skin patch capable of monitoring the size of tumors lying just under the skin, a development that has been successfully tested on mice.

Researchers from National Tsing Hua University (Hsinchu, Taiwan) and Taipei Medical University (Taipei, Taiwan) discovered a simpler method for measuring tumors just under the skin. They developed a skin patch that continuously monitors tumor size through a smartphone application. The patch, resembling a flexible sticker, is made from soft, elastic plastic with an adhesive on one side. To transform this into a monitoring device, the team incorporated hafnium, a metal formed by combining silver and oxygen, into the plastic. This metal was processed into nanoparticles of 100 nm in size and then mixed with the plastic.

Once the patch is applied over a tumor, the patch properties are altered by changes in the alignment of the nanoparticles and their electrical properties to reveal the size of the tumor. The researchers validated this technology on mice with tumors approximately the size of a grain of rice and found it could accurately monitor the tumor size for up to a week. The research team envisages that, upon further validation and clinical use, this patch would allow patients to personally monitor their treatment progress. Additionally, the data collected by the smartphone app could be sent daily to their healthcare provider, potentially enhancing patient care and treatment monitoring.

Related Links:
National Tsing Hua University
Taipei Medical University


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Critical Care Cart
Avalo
New
Mattress System
Apollo Infant Dynamic
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.